Ignacio Melero, MD, PhD, on Developing and Implementing New Immunotherapies

2015 European Cancer Congress

Ignacio Melero, MD, PhD, of the University Clinic of Navarra, Centre of Applied Medical Research, discusses the latest developments in an important cancer treatment avenue.

Matteo Lambertini, MD, on Preserving Women’s Fertility Through Hormonal Therapy

Matteo Lambertini, MD, Dana-Farber Cancer Institute, discusses the use of LHRH agonists during chemotherapy to suppress ovarian function as a way to preserve fertility in breast cancer patients (Abstract 1957).

Colorectal Cancer

Michel Ducreux, MD, PhD

Michel Ducreux, MD, PhD, on Results of the Phase II COLO 001 Clinical Trial

Michel Ducreux, MD, PhD, of the Institut Gustave Roussy, discusses the efficacy and safety in this study of nab-paclitaxel in patients with previously treated metastatic colorectal cancer (Abstract 2131).

Solid Tumors

CNS Cancers

Priscilla K. Brastianos, MD

Priscilla K. Brastianos, MD, on Genetic Screening of Brain Metastases

Priscilla K. Brastianos, MD, of Massachusetts General Hospital, discusses genomic characterization of brain metastases and paired primary tumors, which could reveal potential therapeutic targets (Abstract 2905).

Lung Cancer

M. Catherine Pietanza, MD

M. Catherine Pietanza, MD, on A Promising New Agent for SCLC

M. Catherine Pietanza, MD, of Memorial Sloan Kettering Cancer Center, discusses rovalpituzumab tesirine, a promising DLL3-targeted antibody drug conjugate, the first precision treatment for small cell lung cancer (Abstract 7LBA).

Skin Cancer

Shailender Bhatia, MD

Shailender Bhatia, MD, on Merkel Cell Carcinoma: Final Results of a Phase II Study

Shailender Bhatia, MD, of the Fred Hutchinson Cancer Center, discusses his paper on interleukin-12 DNA and regression of Merkel cell tumors (Abstract 504).

Sep

Today In Oncology

Ignacio Melero, MD, PhD, on Developing and Implementing New Immunotherapies

Related Videos

Matteo Lambertini, MD, on Preserving Women’s Fertility Through Hormonal Therapy

Michel Ducreux, MD, PhD, on Results of the Phase II COLO 001 Clinical Trial

Priscilla K. Brastianos, MD, on Genetic Screening of Brain Metastases

M. Catherine Pietanza, MD, on A Promising New Agent for SCLC

Shailender Bhatia, MD, on Merkel Cell Carcinoma: Final Results of a Phase II Study

AI’s Evolving Role in Clinical Care Enterprise-Wide

FDA Approves Zanidatamab Combination Regimens for HER2 Gastric GEJ or Esophageal Cancer

High-Risk Prostate Cancer GETUG-AFU 18 Suggests a Role for Dose-Escalated Radiotherapy With Long-Term ADT

First-Line Trastuzumab Deruxtecan Prolongs PFS in HER2-Mutant NSCLC

Zipalertinib Added to Chemotherapy Improves PFS in First-Line EGFR Exon 20 NSCLC